DDX17 can induce intron 3 retention of PXN-AS1 in hepatocellular carcinoma cells to produce PXN-AS1-IR3, which activates the MYC signaling pathway and promotes tumor progression by binding to Tex10. Here, DDX17 is linked to neoplasm.